At Emmes Group, our work is driven by a simple but profound belief: truth matters. Since our founding in 1977, we’ve been committed to uncovering truth in clinical research – through scientific rigor, operational excellence, and deep collaboration with our clients and partners. That truth fuels better decisions, faster treatments, and more confident health outcomes.
News
Press Release
Emmes Group® names Germaine Gross Chief Commercial Officer o…
Press Release
Emmes adds new role as it looks to expand government footpri…
Press Release
Emmes awarded multi-task, IDIQ contract with $50M ceiling, t…
Article
Rare Disease Day: Emmes Endpoints Solutions submits Duchenne…
Press Release
Dr. Rama Kondru Named Chief Executive Officer of Veridix AI
Press Release
Creation of the Emmes Group Will Advance Company’s 47-year L…
Our Brands
RFP
Submit an RFP Document
2,150+
Phase I–IV trials in
90+ countries
434+
Publications in scientific
journals since 2016
32,000+
Clinical trial sites
History
Founded as Emmes more than 47 years ago, Emmes Group has grown to become one of the primary clinical research providers to the US government before expanding into public-private partnerships and commercial biopharma.
Leadership
We are led by a dynamic team of visionaries who bring a wealth of experience, expertise and passion to drive our mission.
